Literature DB >> 32997910

Myelodysplastic Syndromes.

Mario Cazzola1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32997910     DOI： 10.1056/NEJMra1904794

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  57 in total

1.  Clinical, molecular, and prognostic comparisons between CCUS and lower-risk MDS: a study of 187 molecularly annotated patients.

Authors:  Marissa Li; Moritz Binder; Terra Lasho; Alejandro Ferrer; Naseema Gangat; Aref Al-Kali; Abhishek Mangaonkar; Michelle Elliott; Mark Litzow; William Hogan; Animesh Pardanani; Alexandra Wolanskyj-Spinner; Matthew Howard; Rebecca L King; Mithun Shah; Hassan Alkhateeb; Kebede Begna; Ayalew Tefferi; Christy Finke; Jennifer Oliveira; Rhett Ketterling; Horatiu Olteanu; Mrinal M Patnaik
Journal:  Blood Adv       Date:  2021-04-27

2.  Immune Dysregulation and Recurring Mutations in Myelodysplastic Syndromes Pathogenesis.

Authors:  Anacélia Matos; Silvia M M Magalhães; Michael J Rauh
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 3.  Cedazuridine/decitabine: from preclinical to clinical development in myeloid malignancies.

Authors:  Anand A Patel; Kirk Cahill; Caner Saygin; Olatoyosi Odenike
Journal:  Blood Adv       Date:  2021-04-27

4.  Combination of HDE and BIIB021 efficiently inhibits cell proliferation and induces apoptosis via downregulating hTERT in myelodysplastic syndromes.

Authors:  Bo Wang; Jianping Jiang; Yun Zhang; Yingying Shen; Liqiang Wu; Siqi Tang; Shengyun Lin
Journal:  Exp Ther Med       Date:  2021-03-17       Impact factor: 2.447

5.  miR-23a mediates resistance to hypomethylating agents in myeloid neoplasms.

Authors:  Marie-Christina Mayer; Johannes Lorenz Berg; Bianca Perfler; Stefan Hatzl; Sereina Annik Herzog; Gerhard Bachmaier; Andrea Berghold; Andreas Reinisch; Albert Wölfler; Heinz Sill; Armin Zebisch
Journal:  Ann Hematol       Date:  2021-07-22       Impact factor: 3.673

Review 6.  Prognostic mutation constellations in acute myeloid leukaemia and myelodysplastic syndrome.

Authors:  Ilaria Iacobucci; Charles G Mullighan
Journal:  Curr Opin Hematol       Date:  2021-03-01       Impact factor: 3.284

Review 7.  JAK-STAT in Early Hematopoiesis and Leukemia.

Authors:  Eirini Sofia Fasouli; Eleni Katsantoni
Journal:  Front Cell Dev Biol       Date:  2021-05-14

8.  Bone marrow-derived mesenchymal stem/stromal cells in patients with acute myeloid leukemia reveal transcriptome alterations and deficiency in cellular vitality.

Authors:  Leisheng Zhang; Ying Chi; Yimeng Wei; Wenxia Zhang; Fuxu Wang; Lei Zhang; Linglin Zou; Baoquan Song; Xing Zhao; Zhongchao Han
Journal:  Stem Cell Res Ther       Date:  2021-06-26       Impact factor: 6.832

9.  Common clonal origin of chronic myelomonocytic leukemia and B-cell acute lymphoblastic leukemia in a patient with a germline CHEK2 variant.

Authors:  Alexandre Bazinet; John Heath; Anne-Sophie Chong; Estelle R Simo-Cheyou; Samantha Worme; Barbara Rivera Polo; William D Foulkes; Stephen Caplan; Nathalie A Johnson; Alexandre Orthwein; François E Mercier
Journal:  Cold Spring Harb Mol Case Stud       Date:  2021-06-11

Review 10.  Innate immune pathways and inflammation in hematopoietic aging, clonal hematopoiesis, and MDS.

Authors:  Jennifer J Trowbridge; Daniel T Starczynowski
Journal:  J Exp Med       Date:  2021-06-15       Impact factor: 17.579
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.